BR112013018453A2 - métodos e composições para a prevenção e tratamento de osteoartrite - Google Patents

métodos e composições para a prevenção e tratamento de osteoartrite

Info

Publication number
BR112013018453A2
BR112013018453A2 BR112013018453A BR112013018453A BR112013018453A2 BR 112013018453 A2 BR112013018453 A2 BR 112013018453A2 BR 112013018453 A BR112013018453 A BR 112013018453A BR 112013018453 A BR112013018453 A BR 112013018453A BR 112013018453 A2 BR112013018453 A2 BR 112013018453A2
Authority
BR
Brazil
Prior art keywords
osteoarthritis
prevention
compositions
treatment
methods
Prior art date
Application number
BR112013018453A
Other languages
English (en)
Portuguese (pt)
Inventor
Paul Middleton Rondo
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BR112013018453A2 publication Critical patent/BR112013018453A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Birds (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR112013018453A 2010-12-21 2011-12-15 métodos e composições para a prevenção e tratamento de osteoartrite BR112013018453A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201061459902P 2010-12-21 2010-12-21
PCT/US2011/065173 WO2012087745A1 (en) 2010-12-21 2011-12-15 Methods and compositions for preventing and treating osteoarthritis

Publications (1)

Publication Number Publication Date
BR112013018453A2 true BR112013018453A2 (pt) 2018-05-22

Family

ID=46314373

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013018453A BR112013018453A2 (pt) 2010-12-21 2011-12-15 métodos e composições para a prevenção e tratamento de osteoartrite

Country Status (11)

Country Link
US (1) US20140205569A1 (enExample)
EP (1) EP2654744A4 (enExample)
JP (1) JP2014505679A (enExample)
CN (1) CN103384521A (enExample)
AU (1) AU2011349718B2 (enExample)
BR (1) BR112013018453A2 (enExample)
CA (1) CA2822263A1 (enExample)
MX (1) MX2013007191A (enExample)
RU (1) RU2013133998A (enExample)
WO (1) WO2012087745A1 (enExample)
ZA (1) ZA201305497B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
WO2014022816A2 (en) * 2012-08-03 2014-02-06 Dignity Sciences Limited Pharmaceutical compositions comprising 15-hetre and methods of treating or preventing arthritis using same
US9682055B2 (en) 2014-06-04 2017-06-20 Dignity Sciences Limted Pharmaceutical compositions comprising DGLA and use of same
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE49783B1 (en) * 1979-05-18 1985-12-11 Efamol Ltd Pharmaceutical and dietary composition comprising epsilon-linolenic acids
GB9403855D0 (en) * 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
GB9403857D0 (en) * 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
KR100490189B1 (ko) * 1995-08-07 2005-05-17 산토리 가부시키가이샤 오메가 9계 불포화 지방산을 포함하는, 연골 조직의 이상에 기인하는 의학적 증상의 예방 또는 치료제
GB9622636D0 (en) * 1996-10-30 1997-01-08 Scotia Holdings Plc Presentation of bioactives
GB9710351D0 (en) * 1997-05-20 1997-07-16 Scotia Holdings Plc Glucosamine fatty acids
EP1290136B1 (en) * 2000-05-25 2006-05-10 Société des Produits Nestlé S.A. Probiotics for pet food applications
US20020188024A1 (en) * 2000-08-23 2002-12-12 Chilton Floyd H. Fatty acid-containing emulsion with increased bioavailability
DE602004015472D1 (de) * 2003-08-11 2008-09-11 Hills Pet Nutrition Inc Omega-3-fettsäuren zur behandlung von osteoarthritis bei hunden
US8633247B2 (en) * 2003-08-11 2014-01-21 Hill's Pet Nutrition, Inc. Method for decreasing cartilage damage in dogs
US8652532B2 (en) * 2003-11-21 2014-02-18 Nestec S.A. Food composition comprising glucosamine
US8637495B2 (en) * 2004-07-01 2014-01-28 Nestec S.A. Osteoarthritis diet formulations
CA2599112C (en) * 2005-02-14 2013-10-22 Suntory Limited Composition comprising dihomo-.gamma.-linolenic acid (dgla) as the active ingredient
CA2648273A1 (en) * 2006-04-03 2007-10-11 Nestec S.A. Nutritional compositions for promotion of bone growth and maintenance of bone health and methods regarding same

Also Published As

Publication number Publication date
ZA201305497B (en) 2015-01-28
EP2654744A4 (en) 2014-07-02
US20140205569A1 (en) 2014-07-24
CA2822263A1 (en) 2012-06-28
AU2011349718B2 (en) 2017-02-09
MX2013007191A (es) 2013-07-12
AU2011349718A1 (en) 2013-07-04
WO2012087745A1 (en) 2012-06-28
RU2013133998A (ru) 2015-01-27
JP2014505679A (ja) 2014-03-06
EP2654744A1 (en) 2013-10-30
CN103384521A (zh) 2013-11-06

Similar Documents

Publication Publication Date Title
BR112013018754A2 (pt) combinação de componentes para a prevenção e tratamento de fragilidade
BR112012004979A2 (pt) composições para o tratamento de semente e métodos
BR112013033534A2 (pt) métodos e composições para inibição de reabsorção de osso
BR112013014943A2 (pt) compostos úteis para o tratamento de aids
PT2640399T (pt) Métodos e composições para a modulação de pd1
PT2523661T (pt) Inibidores de nkcc para o tratamento de autismo
ZA201304280B (en) Treatment of jak2-mediated conditions
HRP20181615T1 (hr) Terapijsko sredstvo koje izaziva citotoksičnost
BR112014010164A2 (pt) implante de tecido duro
EP2575450A4 (en) CYCLOPROPENZUSAMMENSETZUNGEN
CO6801724A2 (es) Composiciones y métodos para el tratamiento de la mielofibrosis
PT2512502T (pt) Métodos e composições para supressão de tumores
BR112013018875A2 (pt) métodos e composições para a preparação de noribogaína a partir de voacangina
BRPI1007972A2 (pt) composições de combinação e métodos para o tratamento de câncer
ITTO20110641A1 (it) Composizioni farmaceutiche e metodi di trattamento
PT2632452T (pt) Compostos e composições para o tratamento do cancro
BR112012004080A2 (pt) composições farmacêuticas para tratar ibd
SG2014014724A (en) METHODS FOR THE TREATMENT OF IL-1ß RELATED CONDITIONS
DK2734212T3 (da) Sammensætninger omfattende diclofenac til behandling af postoperativ smerte
EP2590674A4 (en) COMPOSITIONS AND METHODS FOR INFLUENZA TREATMENT
BR112014004416A2 (pt) composições e métodos para o tratamento de doenças neurodegenerativas
BRPI1013927A2 (pt) métodos e composições para o tratamento de lúpus
EP2755486A4 (en) DISINFECTING COMPOSITIONS AND USES THEREOF
HRP20180687T1 (hr) Kompozicije i metode za liječenje celijakije spru
EP2624836A4 (en) BEPOTASTIN COMPOSITION

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2494 DE 23-10-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.